UK Government Builds £2 Billion Plan for Bioengineering, Including Investment into Cultivated Meat & Seafood
Welcome to the World’s Largest Industry-Dedicated Gathering for mRNA Professionals
Join 400+ mRNA experts and enthusiasts to hear previously-unseen data insights from 65+ world-class speakers from the likes of CureVac, Moderna, BioNTech and Sanofi, and gain exclusive regulatory insights from the FDA, MHRA and EMA.
About
2023 saw the Nobel Prize awarded to mRNA technology, reinvigorating the field and spurring a new wave of candidates entering the clinic. The industry has made tremendous strides in applying mRNA technology beyond COVID-19, and as mRNA unlocks the rare, infectious and oncological spaces, the 4th mRNA-Based Therapeutics Summit cements its position as the world's largest, end-to-end mRNA conference, bringing you exclusive scientific and strategic insights from the biggest players across indications and modalities.
Join 400+ mRNA experts and enthusiasts to hear previously-unseen data insights from 65+ world-class speakers from the likes of CureVac, Moderna, BioNTech and Sanofi, and gain exclusive regulatory insights from the FDA, MHRA and EMA.
Personalize your experience and select which sessions best apply to you, by navigating through 4 tracks of content catering to discovery, translation, clinical development and chemistry, manufacturing and controls. Join interactive roundtables and a CEOs’ Panel Discussion, choose from the Regulatory Affairs Strategy or Next Generation mRNA Delivery focus days, and forge meaningful connections in the dedicated networking sessions.
Speakers
A Snapshot of the 65+ Speaker Faculty
Official Partners
Expertise Partners
Explore Related Events
Our 7 content tracks and 130+ expert speakers will cover everything from discovery to clinical
development to manufacturing to clinical operations and provide all the insights needed to
accelerate your cell therapy drug development.
Access 9+ hours of dedicated networking including structured sessions, drinks receptions,
private lunches, 1-1 meetings and more provides the perfect opportunity for you to engage with leading biopharma and stakeholders.
Join 1,000+ attendees spanning all functions and stages of development and deep dive into
key challenges including autoimmune indications, solid tumors, investment, automation
and fundamentals.